Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

TGF-β receptor type II costameric localization in cardiomyocytes and host cell TGF-β response is disrupted by Trypanosoma cruzi infection.

Calvet CM, Silva TA, DE Melo TG, DE Araújo-Jorge TC, Pereira MC.

Parasitology. 2016 May;143(6):704-15. doi: 10.1017/S0031182016000299. Epub 2016 Mar 21.

PMID:
26996782
2.

SB-431542, a transforming growth factor beta inhibitor, impairs Trypanosoma cruzi infection in cardiomyocytes and parasite cycle completion.

Waghabi MC, Keramidas M, Calvet CM, Meuser M, de Nazaré C Soeiro M, Mendonça-Lima L, Araújo-Jorge TC, Feige JJ, Bailly S.

Antimicrob Agents Chemother. 2007 Aug;51(8):2905-10. Epub 2007 May 25.

3.

Regulation of extracellular matrix expression and distribution in Trypanosoma cruzi-infected cardiomyocytes.

Calvet CM, Oliveira FO Jr, Araújo-Jorge TC, Pereira MC.

Int J Med Microbiol. 2009 Apr;299(4):301-12. doi: 10.1016/j.ijmm.2008.08.005. Epub 2008 Oct 16.

PMID:
18929503
4.

Trypanosoma cruzi infection disrupts vinculin costameres in cardiomyocytes.

Melo TG, Almeida DS, de Meirelles Mde N, Pereira MC.

Eur J Cell Biol. 2004 Oct;83(10):531-40.

PMID:
15679099
5.

Gap junction reduction in cardiomyocytes following transforming growth factor-beta treatment and Trypanosoma cruzi infection.

Waghabi MC, Coutinho-Silva R, Feige JJ, Higuchi Mde L, Becker D, Burnstock G, Araújo-Jorge TC.

Mem Inst Oswaldo Cruz. 2009 Dec;104(8):1083-90.

6.

Uptake of host cell transforming growth factor-beta by Trypanosoma cruzi amastigotes in cardiomyocytes: potential role in parasite cycle completion.

Waghabi MC, Keramidas M, Bailly S, Degrave W, Mendonça-Lima L, Soeiro Mde N, Meirelles Mde N, Paciornik S, Araújo-Jorge TC, Feige JJ.

Am J Pathol. 2005 Oct;167(4):993-1003.

7.

Trypanosoma cruzi coaxes cardiac fibroblasts into preventing cardiomyocyte death by activating nerve growth factor receptor TrkA.

Aridgides D, Salvador R, PereiraPerrin M.

PLoS One. 2013;8(2):e57450. doi: 10.1371/journal.pone.0057450. Epub 2013 Feb 21.

8.
9.

Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells.

Anumanthan G, Halder SK, Osada H, Takahashi T, Massion PP, Carbone DP, Datta PK.

Br J Cancer. 2005 Nov 14;93(10):1157-67.

11.

Trypanosoma cruzi highjacks TrkC to enter cardiomyocytes and cardiac fibroblasts while exploiting TrkA for cardioprotection against oxidative stress.

Aridgides D, Salvador R, PereiraPerrin M.

Cell Microbiol. 2013 Aug;15(8):1357-66. doi: 10.1111/cmi.12119. Epub 2013 Mar 14.

12.

A soluble factor from Trypanosoma cruzi inhibits transforming growth factor-ß-induced MAP kinase activation and gene expression in dermal fibroblasts.

Mott GA, Costales JA, Burleigh BA.

PLoS One. 2011;6(9):e23482. doi: 10.1371/journal.pone.0023482. Epub 2011 Sep 8.

13.

TGF-β sensitivity is determined by N-linked glycosylation of the type II TGF-β receptor.

Kim YW, Park J, Lee HJ, Lee SY, Kim SJ.

Biochem J. 2012 Aug 1;445(3):403-11. doi: 10.1042/BJ20111923.

14.

TGF-beta regulates pathology but not tissue CD8+ T cell dysfunction during experimental Trypanosoma cruzi infection.

Martin DL, Postan M, Lucas P, Gress R, Tarleton RL.

Eur J Immunol. 2007 Oct;37(10):2764-71. Erratum in: Eur J Immunol. 2007 Dec;37(12):3605.

15.

Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.

Meng XM, Huang XR, Xiao J, Chen HY, Zhong X, Chung AC, Lan HY.

J Pathol. 2012 Jun;227(2):175-88. doi: 10.1002/path.3976. Epub 2012 Feb 22.

PMID:
22190171
16.

SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.

Liu S, Nheu T, Luwor R, Nicholson SE, Zhu HJ.

J Biol Chem. 2015 Jul 17;290(29):17894-908. doi: 10.1074/jbc.M114.607184. Epub 2015 Jun 1.

17.
18.

Proteins involved on TGF-β pathway are up-regulated during the acute phase of experimental Chagas disease.

Ferreira RR, de Souza EM, de Oliveira FL, Ferrão PM, Gomes LH, Mendonça-Lima L, Meuser-Batista M, Bailly S, Feige JJ, de Araujo-Jorge TC, Waghabi MC.

Immunobiology. 2016 May;221(5):587-94. doi: 10.1016/j.imbio.2016.01.009. Epub 2016 Jan 29.

PMID:
26852285
19.

TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling.

Tazat K, Hector-Greene M, Blobe GC, Henis YI.

Mol Biol Cell. 2015 Oct 1;26(19):3535-45. doi: 10.1091/mbc.E15-04-0203. Epub 2015 Aug 12.

20.

Retromer maintains basolateral distribution of the type II TGF-β receptor via the recycling endosome.

Yin X, Murphy SJ, Wilkes MC, Ji Y, Leof EB.

Mol Biol Cell. 2013 Jul;24(14):2285-98. doi: 10.1091/mbc.E13-02-0093. Epub 2013 May 29.

Supplemental Content

Support Center